Tag: Msd

First approved by the FDA in 2014 for treating metastatic melanoma, the cancer immunotherapy drug Keytruda is one of the world's best-selling medicines. For patients and healthcare professionals, understanding which pharma company makes KEYTRUDA is important for tracing its origins and development. The answer is the pharmaceutical giant Merck & Co., Inc., also known as MSD outside the United States and Canada.

Originally developed by Bayer Healthcare Pharmaceuticals, the medication riociguat (brand name Adempas) is now part of a global collaboration involving both Bayer and Merck (known as MSD outside the US). This partnership governs the development and commercialization of this important treatment for specific forms of pulmonary hypertension.